Super Vilitra (vardenafil + dapoxetine)
Super Vilitra combines vardenafil 20 mg with dapoxetine 60 mg. Understand both ingredients and the cautions for this combination.
- Active ingredients
- Vardenafil + Dapoxetine
- Form
- Tablet
- Company
- Centurion Laboratories Pvt Ltd
Super Vilitra is documented through Centurion and an Indian pharmacy record as vardenafil 20 mg plus dapoxetine 60 mg. It differs in composition from plain Vilitra, rather than being an interchangeable strength of that family.
The vardenafil form still matters
The reference vardenafil evidence distinguishes film-coated and orodispersible formulations with different exposure. A combined Super Vilitra tablet should not inherit those formulation results without a matching comparison. Its listed vardenafil amount does not prove equivalence to every 20 mg presentation.
Vardenafil also brings QT-related precautions and metabolic interactions. Dapoxetine adds serotonergic and fainting considerations. Those are separate assessment points, even when both ingredients appear in a single tablet.
Clinical research needs an exact scope
A study of dapoxetine added to stable PDE5 treatment in selected men is relevant background, but not a randomized trial of this named product. Some regional Priligy prescribing information advises against PDE5 co-use. The dapoxetine page explains the difference between that clinical evidence and local product restrictions.
The catalogue and pharmacy sources support an identity association, not worldwide permission to supply or a guarantee of an individual’s response. Read the vardenafil article and ask which condition each component is intended to address before treating the combined brand as the obvious next step.
Product record
- Company
- Centurion Laboratories Pvt Ltd
- Strengths listed
- Vardenafil 20 mg + dapoxetine 60 mg
- Treatment area
- Erectile dysfunction (ED); Premature ejaculation (PE)
- Where we found it
- We found it listed by Indian online pharmacy databases (PharmEasy) in October 2026. The database entry does not establish current stock.
- Record reviewed
- 4 October 2026; source retrieval dates are retained with the evidence
Listed strengths identify a product; they are not dosing advice. A listing in one country does not show that a product is authorized where you live.
About vardenafil
Vardenafil film-coated and orodispersible reference tablets are not bioequivalent. A dissolving form does not establish that every jelly or Professional product works faster. QT-related history and interacting medicines need review.
About dapoxetine
Dapoxetine has defined regional PE indications and on-demand trial evidence. Control and distress matter as well as measured minutes. Fainting, alcohol and interacting medicines need review; standalone evidence does not validate every ED/PE combination.
About Indian brands
Indian-company brands have different retail and catalogue evidence. A pharmacy database entry does not establish current stock, and absence from a checked database does not prove export-only manufacture. Company association, exact product identity and local authorization are separate questions.
About fixed combinations
A fixed combination puts two medicines in one tablet at set doses. Each ingredient brings its own side effects and interactions, and approval of each ingredient on its own does not mean the combination is approved or suitable.
Do not add another ED or PE medicine to a combination product.
Using a PDE5 inhibitor safely
Never take a PDE5 inhibitor with nitrates, recreational nitrites (“poppers”) or riociguat, and do not combine two ED medicines. Seek urgent medical help for chest pain, an erection lasting more than four hours, or sudden loss of vision or hearing.
Common side effects include headache, flushing, indigestion and a blocked nose.
Sources
4 sources
Checked .
- Super Vilitra Strip Of 10 Tablets — PharmEasy (India)
- Erectile Dysfunction Medicine — Centurion Laboratories (company catalogue)
- Vardenafil hydrochloride tablets: US prescribing information — DailyMed, US National Library of Medicine. Ingredient reference; it does not describe this brand.
- Priligy (dapoxetine 30 mg) Australian register entry — Therapeutic Goods Administration (Australia). Ingredient reference; it does not describe this brand.